Emerging Trends in Medical Technology: The Role of AI

Scott MacKenzie hosts a podcast at IoT Solutions World Congress Barcelona, featuring Oscar and Anna from ERNI, a Swiss company specializing in software development for IoT and cloud solutions. ERNI does not own IP but helps clients develop and integrate software into their systems, including legacy systems. They emphasize long-term relationships and continuous improvement through Agile methodologies. In the medical sector, ERNI faces challenges with data security and resistance to cloud adoption. Trends include AI and image processing for cancer diagnostics. ERNI's approach balances innovation with practical, secure solutions, making them a valuable partner for companies seeking to enhance their technology capabilities.

Action Items

• [ ] Connect with Ana on LinkedIn
• [ ] Connect with Oscar on LinkedIn

Outline

IoT Solutions World Congress Introduction

• Scott MacKenzie introduces the podcast and its focus on celebrating industry professionals.
• The event is held at IoT Solutions World Congress Barcelona, emphasizing its importance and relevance.
• Scott highlights the conference as a must-attend event for the following year.
• The conference is described as a collection of individuals solving today's industrial challenges.

Introduction of Oscar and Ana from ERNI

• Scott introduces Oscar and Ana from ERNI, a company with a unique name.
• Oscar explains that the name ERNI is an acronym for the owner's son.
• Scott and the team discuss the benefits of attending the conference, including competition insights and trend identification.
• Oscar emphasizes that ERNI helps companies elevate their game by making their competition better.

Background of ERNI and Its Unique Approach

• Oscar shares his seven-year experience in the med tech sector and IoT.
• Ana, an account manager, has a master's degree in telecommunications and has been with ERNI for 10 years.
• ERNI is a Swiss company with a presence in Spain for almost 13 years.
• Oscar explains that ERNI provides services to customers without developing their own IP, focusing on software and IoT solutions.

Discovery Meetings and Customer Needs

• Anna discusses the importance of discovery meetings to understand customer needs and identify their technology requirements.
• ERNI is not a product company but develops software for other companies, allowing them to work with competitors.
• Scott inquires about the integration of legacy systems with new solutions, and Oscar explains the challenges and solutions.
• The team emphasizes the importance of long-term relationships with customers to provide continuous support and improvement.

Medical Industry Trends and Challenges

• Scott shifts the conversation to trends in the medical industry, particularly the need for custom solutions.
• Oscar highlights the resistance to cloud-based solutions due to security concerns.
• The team discusses the challenges of ensuring data security and the traditional resistance to new technologies in the medical field.
• Scott and the team explore the potential of AI and other technologies to improve medical processes and efficiency.

AI and IoT in the Medical Sector

• Oscar and Anna discuss the potential of AI in image processing and cancer diagnosis.
• The team compares the initial resistance to new technologies like mobile phones to the current skepticism around AI.
• Scott emphasizes the need for standards and guardrails in the AI space to ensure reliable and effective implementation.
• The team agrees that AI can help doctors by processing large amounts of data and improving diagnostic accuracy.

Conclusion and Contact Information

• Scott wraps up the conversation, expressing his appreciation for the insights provided by Oscar and Ana.
• The team shares their contact information for further collaboration and innovation.
• Scott encourages listeners to attend the IoT Solutions World Congress and connect with ERNI for their expertise.
• The podcast concludes with a reminder of the importance of innovation and collaboration in the industrial sector.